Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis
Treatment of rheumatoid arthritis by intraarticular administration of anti-inflammatory drugs encapsulated in drug delivery systems, such as liposomes/niosomes and lipogelosomes/niogelosomes, prolongs the residence time of the drugs in the joint. It was therefore anticipated that liposome/niosome en...
Gespeichert in:
Veröffentlicht in: | Interventional medicine and applied science 2013-06, Vol.5 (2), p.60-69 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 69 |
---|---|
container_issue | 2 |
container_start_page | 60 |
container_title | Interventional medicine and applied science |
container_volume | 5 |
creator | Turker, Selcan Ozer, A Yekta Kiliç, Ekrem Ozalp, Meral Colak, Seyda Korkmaz, Mustafa |
description | Treatment of rheumatoid arthritis by intraarticular administration of anti-inflammatory drugs encapsulated in drug delivery systems, such as liposomes/niosomes and lipogelosomes/niogelosomes, prolongs the residence time of the drugs in the joint. It was therefore anticipated that liposome/niosome entrapment would enhance the efficacy of drugs in the inflammatory sides. Liposomes are good candidates for the local delivery of therapeutic agents, such as diclofenac sodium (DFNa), for intraarticular delivery. Drugs for parenteral delivery must be sterile, and radiation sterilization is a method recognized by pharmacopoeias to achieve sterility of drugs. However, irradiation might also affect the performance of drug delivery systems. One of the most critical points is irradiation dose, because certain undesirable chemical and physical changes may accompany with the treatment, especially with the traditionally applied dose of 25 kGy. The present study aims to determine the effects of gamma irradiation on DFNa-loaded liposomes/niosomes and lipogelosomes/niogelosomes for the treatment of rheumatoid arthritis. |
doi_str_mv | 10.1556/IMAS.5.2013.2.2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3831805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1469216616</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1115-da7d37d7e00beffb8d945f8a2d8869216c568c01b87d133a9a133d69c0c18d0e3</originalsourceid><addsrcrecordid>eNpVUD1PwzAQtRCIVqUzG8rIktQfteMsSFUFpVIRAzBH19hpjeK42A4S_56UlgpuuHv3ofeeDqFrgjPCuZgsn2YvGc8oJiyjGT1DQ4oFSTkupudHTATJB2gcwjvug9Fc4uISDeiUCi4LOkTdAqyF1HgPykDUKmnMzgVn9aR1Zl8TaA_DjW6OC3PCSe287RqIxrVh3yRxq5PoNUSr25i4OvFb3VmIzqgEfNx6E024Qhc1NEGPj3WE3h7uX-eP6ep5sZzPVumOEMJTBbliuco1xmtd12upiimvJVAlpSgoERUXssJkLXNFGIMC-qxEUeGKSIU1G6G7A--uW1utqt6Sh6bceWPBf5UOTPl_05ptuXGfJZOMSMx7gtsjgXcfnQ6xtCZUummg1a4LJZn--BBE9Kc3f7VOIr-_Zt923oYc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469216616</pqid></control><display><type>article</type><title>Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Turker, Selcan ; Ozer, A Yekta ; Kiliç, Ekrem ; Ozalp, Meral ; Colak, Seyda ; Korkmaz, Mustafa</creator><creatorcontrib>Turker, Selcan ; Ozer, A Yekta ; Kiliç, Ekrem ; Ozalp, Meral ; Colak, Seyda ; Korkmaz, Mustafa</creatorcontrib><description>Treatment of rheumatoid arthritis by intraarticular administration of anti-inflammatory drugs encapsulated in drug delivery systems, such as liposomes/niosomes and lipogelosomes/niogelosomes, prolongs the residence time of the drugs in the joint. It was therefore anticipated that liposome/niosome entrapment would enhance the efficacy of drugs in the inflammatory sides. Liposomes are good candidates for the local delivery of therapeutic agents, such as diclofenac sodium (DFNa), for intraarticular delivery. Drugs for parenteral delivery must be sterile, and radiation sterilization is a method recognized by pharmacopoeias to achieve sterility of drugs. However, irradiation might also affect the performance of drug delivery systems. One of the most critical points is irradiation dose, because certain undesirable chemical and physical changes may accompany with the treatment, especially with the traditionally applied dose of 25 kGy. The present study aims to determine the effects of gamma irradiation on DFNa-loaded liposomes/niosomes and lipogelosomes/niogelosomes for the treatment of rheumatoid arthritis.</description><identifier>ISSN: 2061-1617</identifier><identifier>EISSN: 2061-5094</identifier><identifier>DOI: 10.1556/IMAS.5.2013.2.2</identifier><identifier>PMID: 24265892</identifier><language>eng</language><publisher>Hungary: Akadémiai Kiadó</publisher><subject>Hematology, Cancer and Oncology, Gastroenterology and Hepatology, Nephrology and Urology, Pediatrics, Surgery, Medical Research, Clinical Medicine and Cardiovascular and Respiratory Systems ; Original Paper</subject><ispartof>Interventional medicine and applied science, 2013-06, Vol.5 (2), p.60-69</ispartof><rights>Copyright © 2013, Akadémiai Kiadó, Budapest 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831805/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831805/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24265892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turker, Selcan</creatorcontrib><creatorcontrib>Ozer, A Yekta</creatorcontrib><creatorcontrib>Kiliç, Ekrem</creatorcontrib><creatorcontrib>Ozalp, Meral</creatorcontrib><creatorcontrib>Colak, Seyda</creatorcontrib><creatorcontrib>Korkmaz, Mustafa</creatorcontrib><title>Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis</title><title>Interventional medicine and applied science</title><addtitle>Interv Med Appl Sci</addtitle><description>Treatment of rheumatoid arthritis by intraarticular administration of anti-inflammatory drugs encapsulated in drug delivery systems, such as liposomes/niosomes and lipogelosomes/niogelosomes, prolongs the residence time of the drugs in the joint. It was therefore anticipated that liposome/niosome entrapment would enhance the efficacy of drugs in the inflammatory sides. Liposomes are good candidates for the local delivery of therapeutic agents, such as diclofenac sodium (DFNa), for intraarticular delivery. Drugs for parenteral delivery must be sterile, and radiation sterilization is a method recognized by pharmacopoeias to achieve sterility of drugs. However, irradiation might also affect the performance of drug delivery systems. One of the most critical points is irradiation dose, because certain undesirable chemical and physical changes may accompany with the treatment, especially with the traditionally applied dose of 25 kGy. The present study aims to determine the effects of gamma irradiation on DFNa-loaded liposomes/niosomes and lipogelosomes/niogelosomes for the treatment of rheumatoid arthritis.</description><subject>Hematology, Cancer and Oncology, Gastroenterology and Hepatology, Nephrology and Urology, Pediatrics, Surgery, Medical Research, Clinical Medicine and Cardiovascular and Respiratory Systems</subject><subject>Original Paper</subject><issn>2061-1617</issn><issn>2061-5094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVUD1PwzAQtRCIVqUzG8rIktQfteMsSFUFpVIRAzBH19hpjeK42A4S_56UlgpuuHv3ofeeDqFrgjPCuZgsn2YvGc8oJiyjGT1DQ4oFSTkupudHTATJB2gcwjvug9Fc4uISDeiUCi4LOkTdAqyF1HgPykDUKmnMzgVn9aR1Zl8TaA_DjW6OC3PCSe287RqIxrVh3yRxq5PoNUSr25i4OvFb3VmIzqgEfNx6E024Qhc1NEGPj3WE3h7uX-eP6ep5sZzPVumOEMJTBbliuco1xmtd12upiimvJVAlpSgoERUXssJkLXNFGIMC-qxEUeGKSIU1G6G7A--uW1utqt6Sh6bceWPBf5UOTPl_05ptuXGfJZOMSMx7gtsjgXcfnQ6xtCZUummg1a4LJZn--BBE9Kc3f7VOIr-_Zt923oYc</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Turker, Selcan</creator><creator>Ozer, A Yekta</creator><creator>Kiliç, Ekrem</creator><creator>Ozalp, Meral</creator><creator>Colak, Seyda</creator><creator>Korkmaz, Mustafa</creator><general>Akadémiai Kiadó</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201306</creationdate><title>Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis</title><author>Turker, Selcan ; Ozer, A Yekta ; Kiliç, Ekrem ; Ozalp, Meral ; Colak, Seyda ; Korkmaz, Mustafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1115-da7d37d7e00beffb8d945f8a2d8869216c568c01b87d133a9a133d69c0c18d0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Hematology, Cancer and Oncology, Gastroenterology and Hepatology, Nephrology and Urology, Pediatrics, Surgery, Medical Research, Clinical Medicine and Cardiovascular and Respiratory Systems</topic><topic>Original Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turker, Selcan</creatorcontrib><creatorcontrib>Ozer, A Yekta</creatorcontrib><creatorcontrib>Kiliç, Ekrem</creatorcontrib><creatorcontrib>Ozalp, Meral</creatorcontrib><creatorcontrib>Colak, Seyda</creatorcontrib><creatorcontrib>Korkmaz, Mustafa</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Interventional medicine and applied science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turker, Selcan</au><au>Ozer, A Yekta</au><au>Kiliç, Ekrem</au><au>Ozalp, Meral</au><au>Colak, Seyda</au><au>Korkmaz, Mustafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis</atitle><jtitle>Interventional medicine and applied science</jtitle><addtitle>Interv Med Appl Sci</addtitle><date>2013-06</date><risdate>2013</risdate><volume>5</volume><issue>2</issue><spage>60</spage><epage>69</epage><pages>60-69</pages><issn>2061-1617</issn><eissn>2061-5094</eissn><abstract>Treatment of rheumatoid arthritis by intraarticular administration of anti-inflammatory drugs encapsulated in drug delivery systems, such as liposomes/niosomes and lipogelosomes/niogelosomes, prolongs the residence time of the drugs in the joint. It was therefore anticipated that liposome/niosome entrapment would enhance the efficacy of drugs in the inflammatory sides. Liposomes are good candidates for the local delivery of therapeutic agents, such as diclofenac sodium (DFNa), for intraarticular delivery. Drugs for parenteral delivery must be sterile, and radiation sterilization is a method recognized by pharmacopoeias to achieve sterility of drugs. However, irradiation might also affect the performance of drug delivery systems. One of the most critical points is irradiation dose, because certain undesirable chemical and physical changes may accompany with the treatment, especially with the traditionally applied dose of 25 kGy. The present study aims to determine the effects of gamma irradiation on DFNa-loaded liposomes/niosomes and lipogelosomes/niogelosomes for the treatment of rheumatoid arthritis.</abstract><cop>Hungary</cop><pub>Akadémiai Kiadó</pub><pmid>24265892</pmid><doi>10.1556/IMAS.5.2013.2.2</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2061-1617 |
ispartof | Interventional medicine and applied science, 2013-06, Vol.5 (2), p.60-69 |
issn | 2061-1617 2061-5094 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3831805 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Hematology, Cancer and Oncology, Gastroenterology and Hepatology, Nephrology and Urology, Pediatrics, Surgery, Medical Research, Clinical Medicine and Cardiovascular and Respiratory Systems Original Paper |
title | Gamma-irradiated liposome/noisome and lipogelosome/niogelosome formulations for the treatment of rheumatoid arthritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A48%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma-irradiated%20liposome/noisome%20and%20lipogelosome/niogelosome%20formulations%20for%20the%20treatment%20of%20rheumatoid%20arthritis&rft.jtitle=Interventional%20medicine%20and%20applied%20science&rft.au=Turker,%20Selcan&rft.date=2013-06&rft.volume=5&rft.issue=2&rft.spage=60&rft.epage=69&rft.pages=60-69&rft.issn=2061-1617&rft.eissn=2061-5094&rft_id=info:doi/10.1556/IMAS.5.2013.2.2&rft_dat=%3Cproquest_pubme%3E1469216616%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1469216616&rft_id=info:pmid/24265892&rfr_iscdi=true |